Company news
Soligenix, Inc. news in 2019
Soligenix, Inc.'s news releases, calls and decks from 2019, newest first.
Soligenix Initiates Clinical Trial of its Heat Stable Ricin Toxin Vaccine
December 11, 2019
Soligenix Completes Enrollment in its Pivotal Phase 3 Clinical Trial of SGX301 in the Treatment of Cutaneous T-cell Lymphoma
December 2, 2019
Soligenix Announces Recent Accomplishments And Third Quarter 2019 Financial Results
November 11, 2019
Soligenix Receives US Patent for Improved Production of Synthetic Hypericin Composition
October 23, 2019
Soligenix Appoints Daniel P. Ring as Vice President of Business Development and Strategic Planning
September 15, 2019
Soligenix Appoints Jonathan Guarino as Chief Financial Officer
September 10, 2019
Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer
August 27, 2019
Soligenix Announces $150,000 NIH Small Business Innovation Research Award Supporting Evaluation of SGX942 in Pediatric Indications
August 14, 2019
Soligenix Announces Recent Accomplishments And Second Quarter 2019 Financial Results
August 12, 2019
Soligenix Announces Appointment of Diane L. Parks to its Board of Directors
July 7, 2019
Soligenix Announces $600,000 Subaward Supporting Evaluation of Innate Defense Regulator Platform Technology as a Medical Countermeasure for Bacterial Threat Agents
May 27, 2019
Soligenix Announces Recent Accomplishments And First Quarter 2019 Financial Results
May 13, 2019
Soligenix Achieves Significant Enrollment Milestone for its Pivotal Phase 3 Clinical Trial of SGX942 in the Treatment of Oral Mucositis in Head and Neck Cancer
April 17, 2019
Soligenix Receives $611,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program
April 14, 2019
Soligenix and the European Medicines Agency Pediatric Committee Reach Agreement on the Pediatric Investigation Plan for SGX942
April 8, 2019
Soligenix Receives US Patent for Dusquetide Related Analogs
April 3, 2019
Decks in 2019
- Investor Presentation (June 2019)
Investor deck · 23 slides · Jun 12, 2019